Jay Chudow
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Jay Chudow has a total of 20 co-authors. Here are the top co-authors by number of shared publications:
- John D. Fisher
Division of Cardiology, Department of Medicine Montefiore Einstein Medical Center, Albert Einstein College of Medicine Bronx New York USA
2 shared publications Ahmad Naser
Jacobi Medical Center Albert Einstein College of Medicine Bronx New York USA
1 shared publicationAlex Conant
Department of Internal Medicine, Montefiore Medical Center, Bronx, New York, USA
1 shared publicationAmrin Kharawala
Jacobi Medical Center Albert Einstein College of Medicine Bronx New York USA
1 shared publicationAndrew Krumerman
Montefiore Medical Center Albert Einstein College of Medicine Bronx New York USA
1 shared publication- Andrew Krumerman
Department of Medicine, Division of Cardiology Northwell Health, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell Hempstead New York USA
1 shared publication
Latest Publications
- 27 November 2023
- Published by Wiley in Pacing and Clinical Electrophysiology
- Vol. 47 (2) , 185-194
Utilization of the remote monitoring of cardiac implantable electronic devices in a diverse demographic cohort: Insights from a single‐center observation
Background: Despite its clinical benefits, patient compliance to remote monitoring (RM) of cardiac implantable electronic devices (CIEDs) varies and remains under-studied in diverse populations.Objective: We sought to evaluate RM compliance, clinical outcomes, and identify demographic and socioeconomic factors affecting RM in a diverse urban population in New York.Methods: This retrospective cohort study included patients enrolled in CIED RM at Montefiore Medical Center between December 2017 and May 2022. RM compliance was defined as the percentage of days compliant to RM transmission divided by the total prescribed days of RM. Patients were censored when they were lost to follow-up or at the time of death. The cohorts were categorized into low (<= 30%), intermediate (31-69%), and high (>= 70%) RM compliance groups. Statistical analyses were conducted accordingly.Results: Among 853 patients, median RM compliance was 55%. Age inversely affected compliance (p < .001), and high compliance was associated with guideline-directed medical therapy (GDMT) usage and implantable cardioverter defibrillator (ICD)/cardiac resynchronization defibrillator (CRTD) devices. The low-compliance group had a higher mortality rate and fewer regular clinic visits (p < .001) than high-compliance group. Socioeconomic factors did not significantly impact compliance, while Asians showed higher compliance compared with Whites (OR 3.67; 95% CI 1.08-12.43; p = .04). Technical issues were the main reason for non-compliance.Conclusion: We observed suboptimal compliance to RM, which occurred most frequently in older patients. Clinic visit compliance, optimal medical therapy, and lower mortality were associated with higher compliance, whereas insufficient understanding of RM usage was the chief barrier to compliance.
- 27 November 2023
- Published by Wiley in Pacing and Clinical Electrophysiology
- Vol. 47 (2) , 185-194
Utilization of the remote monitoring of cardiac implantable electronic devices in a diverse demographic cohort: Insights from a single‐center observation
Background: Despite its clinical benefits, patient compliance to remote monitoring (RM) of cardiac implantable electronic devices (CIEDs) varies and remains under-studied in diverse populations.Objective: We sought to evaluate RM compliance, clinical outcomes, and identify demographic and socioeconomic factors affecting RM in a diverse urban population in New York.Methods: This retrospective cohort study included patients enrolled in CIED RM at Montefiore Medical Center between December 2017 and May 2022. RM compliance was defined as the percentage of days compliant to RM transmission divided by the total prescribed days of RM. Patients were censored when they were lost to follow-up or at the time of death. The cohorts were categorized into low (<= 30%), intermediate (31-69%), and high (>= 70%) RM compliance groups. Statistical analyses were conducted accordingly.Results: Among 853 patients, median RM compliance was 55%. Age inversely affected compliance (p < .001), and high compliance was associated with guideline-directed medical therapy (GDMT) usage and implantable cardioverter defibrillator (ICD)/cardiac resynchronization defibrillator (CRTD) devices. The low-compliance group had a higher mortality rate and fewer regular clinic visits (p < .001) than high-compliance group. Socioeconomic factors did not significantly impact compliance, while Asians showed higher compliance compared with Whites (OR 3.67; 95% CI 1.08-12.43; p = .04). Technical issues were the main reason for non-compliance.Conclusion: We observed suboptimal compliance to RM, which occurred most frequently in older patients. Clinic visit compliance, optimal medical therapy, and lower mortality were associated with higher compliance, whereas insufficient understanding of RM usage was the chief barrier to compliance.
- Open Access
- 23 September 2022
- Published by Science Repository OU in Journal of Integrative Cardiology Open Access
- Vol. 2022 (3) , 1-4
Accuracy of a Single Versus Multiple Trials of Novel Pacemaker ID Algorithm Mobile Phone App for Identification of Cardiac Devices
Fast and accurate identification of cardiac devices can facilitate device programming and interrogation in various medical settings. We have previously demonstrated the accuracy of the PacemakerID machine learning algorithm for mobile phone cardiac device identification. However, the questions of the reproducibility of this algorithm and whether a single trial sufficiently maximizes accuracy have yet to be answered. Here, we examine 502 chest x-rays performed at a single institution on patients with implantable cardioverter-defibrillators and permanent pacemakers. The PacemakerID mobile phone application was used for five sequential trials on each image and the accuracy of one, three, and five trials were compared. A single trial resulted in a 79% accuracy and 82% positive predictive value with no significant difference (p=0.69) as compared to five trials at identifying device manufacturers. Across all devices, the results of a single trial were not significantly different from those of five trials. Our data demonstrate that a single trial is sufficient to maximize diagnostic accuracy with the PacemakerID mobile phone application, facilitating rapid identification for prompt programming and interrogation of cardiac devices.
- 23 September 2022
- Published by Science Repository OU in Journal of Integrative Cardiology Open Access
- Vol. 2022 (3) , 1-4
Open AccessAccuracy of a Single Versus Multiple Trials of Novel Pacemaker ID Algorithm Mobile Phone App for Identification of Cardiac Devices
Fast and accurate identification of cardiac devices can facilitate device programming and interrogation in various medical settings. We have previously demonstrated the accuracy of the PacemakerID machine learning algorithm for mobile phone cardiac device identification. However, the questions of the reproducibility of this algorithm and whether a single trial sufficiently maximizes accuracy have yet to be answered. Here, we examine 502 chest x-rays performed at a single institution on patients with implantable cardioverter-defibrillators and permanent pacemakers. The PacemakerID mobile phone application was used for five sequential trials on each image and the accuracy of one, three, and five trials were compared. A single trial resulted in a 79% accuracy and 82% positive predictive value with no significant difference (p=0.69) as compared to five trials at identifying device manufacturers. Across all devices, the results of a single trial were not significantly different from those of five trials. Our data demonstrate that a single trial is sufficient to maximize diagnostic accuracy with the PacemakerID mobile phone application, facilitating rapid identification for prompt programming and interrogation of cardiac devices.